Neptune Wellness Solutions Inc (NEPT) Gross Profit Margin starting from the third quarter 2023 to third quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Neptune Wellness Solutions Inc   (NASDAQ: NEPT)


Neptune Wellness Solutions Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEPT Gross Profit Margin (Dec 31 2023)
Q3 		(Sep 30 2023)
Q2 		(Jun 30 2023)
Q1 		(Mar 31 2023)
Q4 		(Dec 31 2022)
Q3
Y / Y Revenue Change -37.75 %
Seq. Revenue Change -13.05 %
Revenue In Millions $7.60
Gross Profit Margin 13.62 %
Gross Profit Margin Total Ranking # 3514
Gross Profit In Millions $1.04
Y / Y Gross Profit Change -44.96 %
Seq. Gross Profit Change -


Commenting Third Quarter 2023 Gross Profit Margin
Neptune Wellness Solutions Inc achieved Gross Profit of $1 millions compare to Gross Loss of $-0.57 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q3 of -13.05 % Neptune Wellness Solutions Inc managed to reduce Cost of Sales and turn into profitability by achieving a Gross Profit of 1 compare to Gross Loss of $-0.57 millions realized in the previous quarter. Company accomplished Gross Profit Margin of 13.62 %, below company average.


Observing third quarter 2023 results within Major Pharmaceutical Preparations industry 157 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 3514.
Learn about Gross Margin
NEPT's Gross Profit Margin third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 158
Healthcare Sector # 492
Overall # 3465

Gross Profit Margin Statistics
High Average Low
31.15 % 15.55 % 9.24 %
(Mar 31 2019)   (Sep 30 2022)


NEPT Gross Income Trends • More of NEPT's Profitabilty Ratios • NEPT Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
NEPT's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
NEPT's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for NEPT's Competitors
Gross Profit Margin Profit Margin for Neptune Wellness Solutions Inc 's Suppliers
Gross Profit Margin Profit Margin for NEPT's Customers

You may also want to know
NEPT's Annual Growth Rates NEPT's Profitability Ratios NEPT's Asset Turnover Ratio NEPT's Dividend Growth
NEPT's Roe NEPT's Valuation Ratios NEPT's Financial Strength Ratios NEPT's Gross Profit Growth
NEPT's Roa NEPT's Inventory Turnover Ratio NEPT's Growth Rates NEPT's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginDec 31 2023 MRQ Gross ProfitDec 31 2023 MRQ Revenue
Tonix Pharmaceuticals Holding Corp   37.36 %$ 1.412  Millions$ 3.779  Millions
Notable Labs Ltd   37.10 %$ 0.115  Millions$ 0.310  Millions
Perrigo Company Plc  36.94 %$ 427.400  Millions$ 1,157.000  Millions
Theralink Technologies Inc   36.93 %$ 0.031  Millions$ 0.084  Millions
Emergent Biosolutions Inc   33.68 %$ 92.900  Millions$ 275.800  Millions
Sunshine Biopharma Inc   33.44 %$ 2.568  Millions$ 7.680  Millions
Lifecore Biomedical Inc   33.24 %$ 9.957  Millions$ 29.957  Millions
Camp4 Therapeutics Corporation  32.80 %$ 17.574  Millions$ 53.574  Millions
Kaya Holdings Inc   32.37 %$ 0.011  Millions$ 0.034  Millions
Phibro Animal Health Corporation  31.49 %$ 78.616  Millions$ 249.616  Millions
Amneal Pharmaceuticals Inc   30.72 %$ 189.827  Millions$ 617.827  Millions
Lftd Partners Inc   29.57 %$ 3.997  Millions$ 13.520  Millions
Intercure Ltd   29.56 %$ 28.567  Millions$ 96.648  Millions
Bridgebio Pharma Inc   28.42 %$ 0.496  Millions$ 1.745  Millions
Societal Cdmo Inc   27.77 %$ 7.698  Millions$ 27.719  Millions
Inmed Pharmaceuticals Inc  26.14 %$ 0.324  Millions$ 1.240  Millions
Hcw Biologics Inc   24.23 %$ 0.253  Millions$ 1.043  Millions
Biolinerx Ltd   23.08 %$ 1.108  Millions$ 4.800  Millions
Evotec Se  22.40 %$ 196.057  Millions$ 875.197  Millions
Catalent Inc   16.70 %$ 171.000  Millions$ 1,024.000  Millions
Neptune Wellness Solutions Inc   13.62 %$ 1.035  Millions$ 7.600  Millions
Rockwell Medical inc   12.99 %$ 2.870  Millions$ 22.093  Millions
Soligenix inc   9.50 %$ 0.023  Millions$ 0.245  Millions
Avid Bioservices Inc   7.14 %$ 2.383  Millions$ 33.383  Millions
Integrated Biopharma Inc  4.94 %$ 0.520  Millions$ 10.520  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.